Screener
Matinas BioPharma MTNB Q4 2025 Annual earnings
Reported March 26, 2026
EPS-$0.24Beat by $1.08
Revenue estimate$25.0K
EPS estimate-$1.32
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$25.0K
EPS estimate-$1.32
Versus estimates
Diluted EPS
Q2 2026-$0.21Beat by $1.11Q1 2026-$0.30Beat by $1.02
Q4 2025-$0.24Beat by $1.08
Q3 2025-$0.40Q2 2025-$1.03Q1 2025-$1.68Miss by $0.90FAQ
- When did Matinas BioPharma report Q4 2025 earnings?
- Matinas BioPharma (MTNB) reported Q4 2025 earnings on March 26, 2026.
- What were Matinas BioPharma's Q4 2025 revenue and EPS?
- Matinas BioPharma reported eps of $-0.24 for Q4 2025.
- Did Matinas BioPharma beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-1.32 by $1.08.
- How did Matinas BioPharma's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 84.0% from $-1.50.
- Where can I find Matinas BioPharma's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-014132) directly on SEC EDGAR. The filing index links above go to sec.gov.
